Information in this section pertains to all global PEN® partners except where country flags are
visible. Click on the flag(s) for country-specific information. If a country flag is not listed, there is
no information specific to that country.
[C] The following conclusions are supported by limited evidence or expert opinion:
No specific recommendations were identified regarding optimal glucose control for individuals undergoing cancer treatment.
Clinical practice guidelines do not specify glycemic targets for individuals undergoing cancer treatment. Clinical guidelines differ in recommended glycemic targets for individuals with co-morbid conditions and limited life expectancy and for individuals in hospital.
Weight should be